ATE491476T1 - Adjuvans von fluorocarbon-emulsionen zur hifu- therapie und verwendung davon - Google Patents

Adjuvans von fluorocarbon-emulsionen zur hifu- therapie und verwendung davon

Info

Publication number
ATE491476T1
ATE491476T1 AT05781799T AT05781799T ATE491476T1 AT E491476 T1 ATE491476 T1 AT E491476T1 AT 05781799 T AT05781799 T AT 05781799T AT 05781799 T AT05781799 T AT 05781799T AT E491476 T1 ATE491476 T1 AT E491476T1
Authority
AT
Austria
Prior art keywords
hifu treatment
enhancement agent
fluoro
target location
core material
Prior art date
Application number
AT05781799T
Other languages
English (en)
Inventor
Zhibiao Wang
Faqi Li
Ziwen Xiao
Yanbing Xiao
Liping Liu
Zhilong Wang
Original Assignee
Chongqing Haifu Hifu Tech Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chongqing Haifu Hifu Tech Co filed Critical Chongqing Haifu Hifu Tech Co
Application granted granted Critical
Publication of ATE491476T1 publication Critical patent/ATE491476T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
    • A61K41/0033—Sonodynamic cancer therapy with sonochemically active agents or sonosensitizers, having their cytotoxic effects enhanced through application of ultrasounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasonic imaging preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasonic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasonic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/226—Solutes, emulsions, suspensions, dispersions, semi-solid forms, e.g. hydrogels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Acoustics & Sound (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT05781799T 2005-01-10 2005-09-02 Adjuvans von fluorocarbon-emulsionen zur hifu- therapie und verwendung davon ATE491476T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN200510000343A CN100574809C (zh) 2005-01-10 2005-01-10 一种高强度聚焦超声治疗用氟碳乳剂类助剂及其应用
PCT/CN2005/001391 WO2006072200A1 (fr) 2005-01-10 2005-09-02 Adjuvant d’emulsions au fluorocarbure pour un traitement hifu et utilisation de celui-ci

Publications (1)

Publication Number Publication Date
ATE491476T1 true ATE491476T1 (de) 2011-01-15

Family

ID=36647408

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05781799T ATE491476T1 (de) 2005-01-10 2005-09-02 Adjuvans von fluorocarbon-emulsionen zur hifu- therapie und verwendung davon

Country Status (13)

Country Link
US (1) US20080138290A1 (de)
EP (1) EP1839677B1 (de)
JP (1) JP2008526786A (de)
KR (1) KR20070094621A (de)
CN (1) CN100574809C (de)
AT (1) ATE491476T1 (de)
AU (1) AU2005324273B2 (de)
BR (1) BRPI0518494A2 (de)
CA (1) CA2593644C (de)
DE (1) DE602005025408D1 (de)
ES (1) ES2355038T3 (de)
RU (1) RU2388492C2 (de)
WO (1) WO2006072200A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2948024B1 (fr) * 2009-07-17 2020-01-10 Centre National De La Recherche Scientifique - Cnrs - Emulsion activable par ultrasons et son procede de fabrication.
EP2768396A2 (de) 2011-10-17 2014-08-27 Butterfly Network Inc. Durchlässige bildgebung sowie zugehörige vorrichtung und verfahren
US9667889B2 (en) 2013-04-03 2017-05-30 Butterfly Network, Inc. Portable electronic devices with integrated imaging capabilities
CN103877598B (zh) * 2014-03-18 2016-04-27 苏晓婷 一种超声造影剂及其制备方法
CN105330786B (zh) * 2014-07-03 2017-07-14 重庆海扶医疗科技股份有限公司 一种治疗用超声耦合介质材料及其制备方法
CN105169420B (zh) * 2015-09-02 2018-01-05 上海市第十人民医院 一种新型射频诊疗剂及其制备方法
FR3082422B1 (fr) 2018-06-14 2021-01-22 Univ D'avignon Et Des Pays De Vaucluse Emulsion pour la chirurgie d'ablation ultrasonore
CN117919402A (zh) * 2023-12-19 2024-04-26 中国科学院宁波材料技术与工程研究所 一种高强度聚焦超声用敏化剂及其制备方法和应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5832829A (ja) * 1981-08-22 1983-02-25 Green Cross Corp:The 血管造影剤
US4767610A (en) * 1984-10-19 1988-08-30 The Regents Of The University Of California Method for detecting abnormal cell masses in animals
US4987154A (en) * 1986-01-14 1991-01-22 Alliance Pharmaceutical Corp. Biocompatible, stable and concentrated fluorocarbon emulsions for contrast enhancement and oxygen transport in internal animal use
US6551576B1 (en) * 1989-12-22 2003-04-22 Bristol-Myers Squibb Medical Imaging, Inc. Container with multi-phase composition for use in diagnostic and therapeutic applications
US6613306B1 (en) * 1990-04-02 2003-09-02 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
DE4127442C2 (de) * 1991-08-17 1996-08-22 Udo Dr Gros Wäßrige Dispersion Fluorcarbon enthaltender Phospholipid-Vesikel und ein Verfahren zu ihrer Herstellung
US5196183A (en) * 1991-12-04 1993-03-23 Sterling Winthrop Inc. Contrast agents for ultrasound imaging
US5716597A (en) * 1993-06-04 1998-02-10 Molecular Biosystems, Inc. Emulsions as contrast agents and method of use
DE69527194T2 (de) * 1994-03-28 2003-02-06 Daiichi Pharmaceutical Co., Ltd. Liposomen enthaltend ein röntgen- oder ultraschallkontrastmittel
US5605934A (en) * 1995-03-23 1997-02-25 Baxter International Inc. Method of manufacturing and storing solutions
ES2197986T3 (es) * 1996-02-19 2004-01-16 Amersham Health As Mejoras introducidas en o relacionadas con agentes de contraste.
US6165442A (en) * 1996-02-19 2000-12-26 Nycomed Imaging As Thermally stabilized ultrasound contrast agent
US5846517A (en) * 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
US6548047B1 (en) * 1997-09-15 2003-04-15 Bristol-Myers Squibb Medical Imaging, Inc. Thermal preactivation of gaseous precursor filled compositions
CN1243753A (zh) * 1998-07-31 2000-02-09 南方医院药学部 一种超声诊断造影剂及其制备方法
CN1194763C (zh) * 2002-09-06 2005-03-30 中国人民解放军第三军医大学 新型脂质体超声造影剂及其制备方法

Also Published As

Publication number Publication date
EP1839677A4 (de) 2008-03-19
JP2008526786A (ja) 2008-07-24
KR20070094621A (ko) 2007-09-20
AU2005324273B2 (en) 2008-08-14
CN100574809C (zh) 2009-12-30
BRPI0518494A2 (pt) 2008-11-25
EP1839677A1 (de) 2007-10-03
DE602005025408D1 (de) 2011-01-27
US20080138290A1 (en) 2008-06-12
WO2006072200A1 (fr) 2006-07-13
AU2005324273A1 (en) 2006-07-13
ES2355038T3 (es) 2011-03-22
RU2007127668A (ru) 2009-01-27
EP1839677B1 (de) 2010-12-15
CN1803196A (zh) 2006-07-19
CA2593644A1 (en) 2006-07-13
RU2388492C2 (ru) 2010-05-10
CA2593644C (en) 2011-06-07

Similar Documents

Publication Publication Date Title
DE502005002436D1 (de) Endochirurgischer bergebeutel für die aufnahme von körpergewebe oder -flüssigkeit
ATE491476T1 (de) Adjuvans von fluorocarbon-emulsionen zur hifu- therapie und verwendung davon
DE602004010407D1 (de) Fluorsubstituierter omega-carboxyaryldiphenylharnstoff zur behandlung und prävention von krankheiten und leiden
WO2007127390A3 (en) Materials and methods for wound treatment
EA201101414A1 (ru) Абсорбирующее изделие
ATE367774T1 (de) Vorrichtung zur abgabe von ablativer laserenergie und zur bestimmung des volumens der zerstörten tumormasse
DE602004025463D1 (de) Verwendung von ciclesonide zur erhaltung des feinen teilchengrössenanteils von formoterol
US11490500B2 (en) Electrode array for a dielectrically impeded plasma treatment
ATE432693T1 (de) Kombinationstherapie zur behandlung von diabetes und dadurch bedingten leiden sowie zur behandlung von mittels erhöhung des glp-1-spiegels im blut verbesserten leiden
DE60327622D1 (de) Kombinierte antitachykardie - schrittmacher und hochspannungstherapie zur behandlung von ventrikulären arrhythmien
ATE538136T1 (de) Antikörper gegen connective tissue growth factor
EP1484366A4 (de) Behandeltes pigment, dessen verwendung und verbindung zur behandlung von pigmenten
DE602005023217D1 (de) Teilchenförmiges adjuvans für hifu-therapie und seine verwendung
ATE497737T1 (de) Implantate beschichtet mit aptameren, die die adhäsion von endothelialen vorläuferzellen vermitteln
ATE423186T1 (de) Emulsion
NO20041024D0 (no) Anvendelse av BIBN4096 i kombinasjon med andre antimigrenelegemidler for behandling av migrene
WO2006067715A3 (en) Method for controlling the flow of liquids containing biological material by inducing electro- or magneto-rheological effect
WO2005115548A3 (en) Treating depressive disorders with carbonic anhydrase activators
WO2007117589A3 (en) Enhanced fc receptor-mediated tumor necrosis factor superfamily and chemokine mrna expression in peripheral blood leukocytes in patients with rheumatoid arthritis
WO2006053788A3 (en) Alterations in seborrheic keratoses and their applications
ATE537805T1 (de) Herstellung und verwendung eines medizinprodukts in der alternativen medizin zur rehabilitationsbehandlung bei chronischen ekrankungen
WO2002085325A3 (de) Herstellung und anwendung einer suspensionszusammensetzung mit einem ultraschall-kontrastmittel
WO2006054289A3 (en) Therapeutic implant
FR2873296B1 (fr) Oscillateur de compensation electrochimique pour la protection biologique des organismes vivants
JP2005029555A (ja) 機能性治療用シート

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties